News


Novan and Sato Advance Japan Market and Dermatology Partnership

MORRISVILLE, N.C., March 19, 2019 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that the Company has named Dr. Elizabeth Messersmith, the Company’s Senior Vice President and Chief Development Officer, the chairperson of the Joint Committee responsible for overseeing the Company’s alliance with Sato Pharmaceutical Co., Ltd. (“Sato”). Dr. Carri Geer, Senior Vice President and Chief Technology Officer, and Dr. Tomoko Maeda-Chubachi, Vice President of Medical Dermatology, serve alongside Dr. Messersmith on the Joint Committee, in addition to three senior members from Sato.